Active Pharmaceutical Ingredients Market by API Synthesis (Biotech API, Synthetic Chemical API, and HPAPI), by Type of Manufacturing (Contract Manufacturing and In-House API Manufacturing), by Type of API (Synthetic API and Biological API), by Drug type (Into Branded Drugs, Generic Drugs and OTC Drugs), for Cardiology, Oncology, Anti-Inflammatory, Gastrointestinal and Other Application – Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Global active pharmaceutical ingredient market to reach USD 213.84 billion in 2021 and is growing at a CAGR of 6.3% during 2016-2021.

The report covers forecast and analysis for the active pharmaceutical ingredient market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the active pharmaceutical ingredient along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the active pharmaceutical ingredient market on a global level.

In order to give the users of this report a comprehensive view on the active pharmaceutical ingredient market, we have included a detailed segmentation of active pharmaceutical ingredient. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the active pharmaceutical ingredient market has also been included. The study encompasses a market attractiveness analysis, wherein type segments and application segments are benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view on the active pharmaceutical ingredient market by segmenting the market based on API synthesis, biotech API, synthetic chemical API and HPAPI. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The active pharmaceutical ingredient market’s manufacturing type segment includes contract manufacturing and in-house API manufacturing. The drug type segment includes branded drugs, generic drugs, and OTC drugs. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific and Rest of the world. This segmentation includes demand for active pharmaceutical ingredient based on individual applications in all the regions.

The key players active in this market are Sun Pharmaceuticals Industries Limited, Novartis International AG, BASF SE, Pfizer, Inc., Aurobindo, Albemarle Corporation, and Boehringer Ingelheim among others.

The report segments the global active pharmaceutical ingredient market as

Active Pharmaceutical Ingredient Market: API Synthesis Segment Analysis

  • Biotech API
  • Synthetic Chemical API
  • HPAPI

Active Pharmaceutical Ingredient Market: Type of Manufacturing Segment Analysis

  • Contract Manufacturing
  • In-House API Manufacturing

Active Pharmaceutical Ingredient Market: Type of API Segment Analysis

  • Synthetic API
  • Biological API

Active Pharmaceutical Ingredient Market: Drug Type Segment Analysis

  • Branded Drugs
  • Generic Drugs
  • OTC Drugs

Active Pharmaceutical Ingredient Market: Therapeutic Application Segment Analysis

  • Cardiology
  • Oncology
  • Anti-Inflammatory
  • Gastrointestinal
  • Other
Table of Contents
  • Chapter 1. Preface
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  • Chapter 2. Executive Summary
    • 2.1. Global Active pharmaceutical ingredient Market, 2015 – 2021, (USD Billion)
    • 2.2. Active pharmaceutical ingredient: Market snapshot
  • Chapter 3. Active pharmaceutical ingredient Market: Industry Analysis
    • 3.1. Active pharmaceutical ingredient: Market dynamics
    • 3.2. Market Drivers
      • 3.2.1. Increasing prevalence of chronic diseases
      • 3.2.2. Technological advancements in the API
      • 3.2.3. Patent expiration of major drugs that increased generic drug sales
      • 3.2.4. Government initiatives
    • 3.3. Restraints
      • 3.3.1. Stringent regulatory requirement
      • 3.3.2. Decline in global economics
    • 3.4. Opportunity
      • 3.4.1. Demand for active pharmaceutical ingredient for various diseases treatment
    • 3.5. Porter’s Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by API synthesis segment
      • 3.6.2. Market attractiveness analysis by type of manufacturing segment
      • 3.6.3. Market attractiveness analysis by type of API segment
      • 3.6.4. Market attractiveness analysis by drug type segment
      • 3.6.5. Market attractiveness analysis by Application segment
      • 3.6.6. Market attractiveness analysis by region segment
  • Chapter 4. Global Active pharmaceutical ingredient Market: Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global active pharmaceutical ingredient market: company market share, 2015
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Product and Regional Expansion
    • 4.3. Price Trend Analysis
    • 4.4. Product Portfolio
    • 4.5. Patent Analysis (2011-2016)
      • 4.5.1. Patent Trend
      • 4.5.2. Patent Share by company
      • 4.5.3. By Region
  • Chapter 5. Global Active pharmaceutical ingredient Market: API Synthesis Type Overview
    • 5.1. Global active pharmaceutical ingredient market share, by API Synthesis type, 2015 and 2021
    • 5.2. Global active pharmaceutical ingredient market for biotech APItype, 2015 – 2021(USD Billion)
    • 5.3. Global active pharmaceutical ingredient market for synthetic chemical API, 2015 – 2021 (USD Billion)
    • 5.4. Global active pharmaceutical ingredient market for HPAPI type, 2015 – 2021 (USD Billion)
  • Chapter 6. Global active pharmaceutical ingredient Market: Type of Manufacturing Overview
    • 6.1. Global active pharmaceutical ingredient market share, by type of Manufacturing, 2015 and 2021
    • 6.2. Global active pharmaceutical ingredient market for contract manufacturing, 2015 – 2021(USD Billion)
    • 6.3. Global active pharmaceutical ingredient market for in-house API manufacturing, 2015 – 2021 (USD Billion)
  • Chapter 7. Global active pharmaceutical ingredient Market: Type of API Overview
    • 7.1. Global active pharmaceutical ingredient market share for type of API , 2015 and 2021
    • 7.2. Global active pharmaceutical ingredient market for synthetic API, 2015 – 2021(USD Billion)
    • 7.3. Global active pharmaceutical ingredient market for biological API, 2015 – 2021 (USD Billion)
  • Chapter 8. Global active pharmaceutical ingredient Market: Drug Type Overview
    • 8.1. Global active pharmaceutical ingredient market share for type of drug, 2015 and 2021
    • 8.2. Global active pharmaceutical ingredient market for branded drugs, 2015 – 2021(USD Billion)
    • 8.3. Global active pharmaceutical ingredient market for generic drugs, 2015 – 2021 (USD Billion)
    • 8.4. Global active pharmaceutical ingredient market for OTC drugs, 2015 – 2021 (USD Billion)
  • Chapter 9. Global active pharmaceutical ingredient Market: Application Overview
    • 9.1. Global active pharmaceutical ingredient market share for application , 2015 and 2021
    • 9.2. Global active pharmaceutical ingredient market for cardiology, 2015 – 2021(USD Billion)
    • 9.3. Global active pharmaceutical ingredient market for oncology, 2015 – 2021 (USD Billion)
    • 9.4. Global active pharmaceutical ingredient market for anti-inflammatory, 2015 – 2021 (USD Billion)
    • 9.5. Global active pharmaceutical ingredient market for gastrointestinal, 2015 – 2021 (USD Billion)
    • 9.6. Global active pharmaceutical ingredient market for others, 2015 – 2021 (USD Billion)
  • Chapter 10. Global active pharmaceutical ingredient Market: Regional Analysis
    • 10.1. Global active pharmaceutical ingredient market: Regional overview
      • 10.1.1. Global active pharmaceutical ingredient market share, by region, 2015 and 2021
    • 10.2. North America
      • 10.2.1. North America active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
      • 10.2.2. North America active pharmaceutical ingredient market revenue, type of Manufacturing, 2015 – 2021 (USD Billion)
      • 10.2.3. North America active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
      • 10.2.4. North America active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
      • 10.2.5. North America active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
      • 10.2.6. U.S.
        • 10.2.6.1. U.S active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
        • 10.2.6.2. U.S active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
        • 10.2.6.3. U.S active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
        • 10.2.6.4. U.S active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
        • 10.2.6.5. U.S active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
    • 10.3. Europe
      • 10.3.1. Europe active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
      • 10.3.2. Europe active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
      • 10.3.3. Europe active pharmaceutical ingredient market revenue, by type of API , 2015 – 2021 (USD Billion)
      • 10.3.4. Europe active pharmaceutical ingredient market revenue, by drug type , 2015 – 2021 (USD Billion)
      • 10.3.5. Europe active pharmaceutical ingredient market revenue, by application , 2015 – 2021 (USD Billion)
      • 10.3.6. UK
        • 10.3.6.1. UK active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
        • 10.3.6.2. UK active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
        • 10.3.6.3. UK active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
        • 10.3.6.4. UK active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
        • 10.3.6.5. UK active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
      • 10.3.7. France
        • 10.3.7.1. France active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
        • 10.3.7.2. France active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
        • 10.3.7.3. France active pharmaceutical ingredient market revenue, by type of API 2015 – 2021 (USD Billion)
        • 10.3.7.4. France active pharmaceutical ingredient market revenue, by drug type 2015 – 2021 (USD Billion)
        • 10.3.7.5. France active pharmaceutical ingredient market revenue, by application 2015 – 2021 (USD Billion)
      • 10.3.8. Germany
        • 10.3.8.1. Germany active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
        • 10.3.8.2. Germany active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
        • 10.3.8.3. Germany active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
        • 10.3.8.4. Germany active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion
        • 10.3.8.5. Germany active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion
    • 10.4. Asia Pacific
      • 10.4.1. Asia Pacific active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
      • 10.4.2. Asia Pacific active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
      • 10.4.3. Asia Pacific active pharmaceutical ingredient market revenue, by type of API , 2015 – 5 – 2021 (USD Billion)
      • 10.4.4. Asia Pacific active pharmaceutical ingredient market revenue, by drug type , 2015 – 5 – 2021 (USD Billion)
      • 10.4.5. Asia Pacific active pharmaceutical ingredient market revenue, by application , 2015 – 5 – 2021 (USD Billion)
      • 10.4.6. China
        • 10.4.6.1. China active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
        • 10.4.6.2. China active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
        • 10.4.6.3. China active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
        • 10.4.6.4. China active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
        • 10.4.6.5. China active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
      • 10.4.7. India
        • 10.4.7.1. India active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
        • 10.4.7.2. India active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
        • 10.4.7.3. India active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
        • 10.4.7.4. India active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
        • 10.4.7.5. India active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
    • 10.5. Latin America
      • 10.5.1. Latin America active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
      • 10.5.2. Latin America active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
      • 10.5.3. Latin America active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
      • 10.5.4. Latin America active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
      • 10.5.5. Latin America active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
      • 10.5.6. Brazil
        • 10.5.6.1. Brazil active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
        • 10.5.6.2. Brazil active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
        • 10.5.6.3. Brazil active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
        • 10.5.6.4. Brazil active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
        • 10.5.6.5. Brazil active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
    • 10.6. Middle East & Africa
      • 10.6.1. Middle East & Africa active pharmaceutical ingredient market revenue, by API Synthesis, 2015 – 2021 (USD Billion)
      • 10.6.2. Middle East & Africa active pharmaceutical ingredient market revenue, by type of Manufacturing, 2015 – 2021 (USD Billion)
      • 10.6.3. Middle East & Africa active pharmaceutical ingredient market revenue, by type of API, 2015 – 2021 (USD Billion)
      • 10.6.4. Middle East & Africa active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
      • 10.6.5. Middle East & Africa active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
  • Chapter 11. Company Profiles
    • 11.1. Novartis International AG
      • 11.1.1. Overview
      • 11.1.2. Financials
      • 11.1.3. Product portfolio
      • 11.1.4. Business strategy
      • 11.1.5. Recent developments
    • 11.2. Pfizer
      • 11.2.1. Overview
      • 11.2.2. Financials
      • 11.2.3. Product portfolio
      • 11.2.4. Business strategy
      • 11.2.5. Recent developments
    • 11.3. Aurobindo
      • 11.3.1. Overview
      • 11.3.2. Financials
      • 11.3.3. Product portfolio
      • 11.3.4. Business strategy
      • 11.3.5. Recent developments
    • 11.4. Albemarle Corporation
      • 11.4.1. Overview
      • 11.4.2. Financials
      • 11.4.3. Product portfolio
      • 11.4.4. Business strategy
      • 11.4.5. Recent developments
    • 11.5. Boehringer Ingelheim
      • 11.5.1. Overview
      • 11.5.2. Financials
      • 11.5.3. Product portfolio
      • 11.5.4. Business strategy
      • 11.5.5. Recent developments
    • 11.6. BASF SE
      • 11.6.1. Overview
      • 11.6.2. Financials
      • 11.6.3. Product portfolio
      • 11.6.4. Business strategy
      • 11.6.5. Recent developments
  • Chapter 12. Patents
    • 12.1. U.S. (US Patents)
    • 12.2. Europe (EP documents)
    • 12.3. Japan (Abstracts of Japan)
    • 12.4. Global (WIPO (PCT))

List of Figures 
1. Global active pharmaceutical ingredient market segmentation API synthesis, type of manufacturing, type of API, type of drug, application, and geography
2. Global active pharmaceutical ingredient  market, 2015 – 2021 (USD Billion)
3. Porter’s five forces analysis: active pharmaceutical ingredient market
4. Market attractiveness analysis by API synthesis segment
5. Market attractiveness analysis by type of manufacturing segment
6. Market attractiveness analysis by type of API segment
7. Market attractiveness analysis by drug type segment
8. Market attractiveness analysis by application segment
9. Market attractiveness analysis by regional segment
10. Global active pharmaceutical ingredient market : Company Market Share, 2015
11. Price Trend Analysis : Active pharmaceutical ingredient market
12. Patent trend between 2011 -2016
13. Patent Share by Company between 2011 – 2016
14. Patent Share by Region between 2011 – 2016
15. Global active pharmaceutical ingredient market share, by API synthesis, 2015 -2021
16. Global active pharmaceutical ingredient market for biotech API, 2015 – 2021 (USD Billion)
17. Global active pharmaceutical ingredient market for synthetic chemical API, 2015 – 2021 (USD Billion)
18. Global active pharmaceutical ingredient market for HPAPI, 2015 – 2021 (USD Billion)
19. Global active pharmaceutical ingredient market share, by type of manufacturing, 2015 -2021
20. Global active pharmaceutical ingredient market for contract manufacturing management (IAM), 2015 – 2021 (USD Billion)
21. Global active pharmaceutical ingredient market for in-house API manufacturing, 2015 – 2021 (USD Billion)
22. Global active pharmaceutical ingredient market share, by type of API, 2015 -2021
23. Global active pharmaceutical ingredient market for synthetic API, 2015 – 2021 (USD Billion)
24. Global active pharmaceutical ingredient market for biological API, 2015 – 2021 (USD Billion)
25. Global active pharmaceutical ingredient market share, by drug type, 2015 -2021
26. Global active pharmaceutical ingredient market for branded drugs, 2015 – 2021 (USD Billion)
27. Global active pharmaceutical ingredient market for generic drugs, 2015 – 2021 (USD Billion)
28. Global active pharmaceutical ingredient market for OTC drugs, 2015 – 2021 (USD Billion)
29. Global active pharmaceutical ingredient market share, by application, 2015 -2021
30. Global active pharmaceutical ingredient market for cardiology, 2015 – 2021 (USD Billion)
31. Global active pharmaceutical ingredient market for oncology, 2015 – 2021 (USD Billion)
32. Global active pharmaceutical ingredient market for anti-inflammatory, 2015 – 2021 (USD Billion)
33. Global active pharmaceutical ingredient market for gastrointestinal, 2015 – 2021 (USD Billion)
34. Global active pharmaceutical ingredient market for others, 2015 – 2021 (USD Billion)
35. Global active pharmaceutical ingredient market share, by region, 2015 – 2021
36. North America active pharmaceutical ingredient market, 2015 – 2021, (USD Billion)
37. U.S. active pharmaceutical ingredient market, 2015 – 2021, (USD Billion)
38. Europe active pharmaceutical ingredient market, 2015 – 2021, (USD Billion)
39. UK active pharmaceutical ingredient market, 2015 – 2021, (USD Billion)
40. France active pharmaceutical ingredient market, 2015 – 2021, (USD Billion)
41. Germany active pharmaceutical ingredient market, 2015 – 2021, (USD Billion)
42. Asia Pacific active pharmaceutical ingredient market, 2015 – 2021, (USD Billion)
43. China active pharmaceutical ingredient market, 2015 – 2021, (USD Billion)
44. Japan active pharmaceutical ingredient market, 2015 – 2021, (USD Billion)
45. India active pharmaceutical ingredient market, 2015 – 2021, (USD Billion)
46. Latin America active pharmaceutical ingredient market, 2015-2021, (USD Billion)
47. Brazil active pharmaceutical ingredient market, 2015 – 2021, (USD Billion)
48. Middle East & Africa active pharmaceutical ingredient market, 2015 – 2021, (USD Billion)


List of Tables

1. Global active pharmaceutical ingredient  market snapshot
2. Drivers for active pharmaceutical ingredient  market: Impact analysis
3. Restraints of active pharmaceutical ingredient  market: Impact analysis
4. North America active pharmaceutical ingredient  market revenue, by API synthesis, 2015 – 2021 (USD Billion)
5. North America active pharmaceutical ingredient  market revenue, by type of manufacturing, 2015 – 2021 (USD Billion)
6. North America active pharmaceutical ingredient  market revenue, by Type of API, 2015 – 2021 (USD Billion)
7. North America active pharmaceutical ingredient  market revenue, by drug type, 2015 – 2021 (USD Billion)
8. North America active pharmaceutical ingredient  market revenue, by application, 2015 – 2021 (USD Billion)
9. U.S. active pharmaceutical ingredient  market revenue, by API synthesis, 2015 – 2021 (USD Billion)
10. U.S. active pharmaceutical ingredient market revenue, by type of manufacturing, 2015 – 2021 (USD Billion)
11. U.S. active pharmaceutical ingredient market revenue, by Type of API, 2015 – 2021 (USD Billion)
12. U.S. active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
13. U.S. active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
14. Europe active pharmaceutical ingredient market revenue, by API synthesis, 2015 – 2021 (USD Billion)
15. Europe active pharmaceutical ingredient market revenue, by type of manufacturing, 2015 – 2021 (USD Billion)
16. Europe active pharmaceutical ingredient market revenue, by Type of API, 2015 – 2021 (USD Billion)
17. Europe active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
18. Europe active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
19. UK active pharmaceutical ingredient market revenue, by API synthesis, 2015 – 2021 (USD Billion)
20. UK active pharmaceutical ingredient market revenue, by type of manufacturing, 2015 – 2021 (USD Billion)
21. UK active pharmaceutical ingredient market revenue, by Type of API, 2015 – 2021 (USD Billion)
22. UK active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
23. UK active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
24. France active pharmaceutical ingredient market revenue, by API synthesis, 2015 – 2021 (USD Billion)
25. France active pharmaceutical ingredient market revenue, by type of manufacturing, 2015 – 2021 (USD Billion)
26. France active pharmaceutical ingredient market revenue, by Type of API, 2015 – 2021 (USD Billion)
27. France active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
28. France active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)
29. Germany active pharmaceutical ingredient market revenue, by API synthesis, 2015 – 2021 (USD Billion)
30. Germany active pharmaceutical ingredient market revenue, by type of manufacturing, 2015 – 2021 (USD Billion)
31. Germany active pharmaceutical ingredient market revenue, by Type of API, 2015 – 2021 (USD Billion)
32. Germany active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
33. Germany active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion
34. Asia-Pacific active pharmaceutical ingredient market revenue, by API synthesis, 2015 – 2021 (USD Billion)
35. Asia-Pacific active pharmaceutical ingredient market revenue, by type of manufacturing, 2015 – 2021 (USD Billion)
36. Asia-Pacific active pharmaceutical ingredient market revenue, by Type of API, 2015 – 2021 (USD Billion)
37. Asia-Pacific active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
38. Asia-Pacific active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion
39. China active pharmaceutical ingredient market revenue, by API synthesis, 2015 – 2021 (USD Billion)
40. China active pharmaceutical ingredient market revenue, by type of manufacturing, 2015 – 2021 (USD Billion)
41. China active pharmaceutical ingredient market revenue, by Type of API, 2015 – 2021 (USD Billion)
42. China active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
43. China active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion
44. Japan active pharmaceutical ingredient market revenue, by API synthesis, 2015 – 2021 (USD Billion)
45. Japan active pharmaceutical ingredient market revenue, by type of manufacturing, 2015 – 2021 (USD Billion)
46. Japan active pharmaceutical ingredient market revenue, by Type of API, 2015 – 2021 (USD Billion)
47. Japan active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
48. Japan active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion
49. India active pharmaceutical ingredient market revenue, by API synthesis, 2015 – 2021 (USD Billion)
50. India active pharmaceutical ingredient market revenue, by type of manufacturing, 2015 – 2021 (USD Billion)
51. India active pharmaceutical ingredient market revenue, by Type of API, 2015 – 2021 (USD Billion)
52. India active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
53. India active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion
54. Latin America active pharmaceutical ingredient market revenue, by API synthesis, 2015 – 2021 (USD Billion)
55. Latin America active pharmaceutical ingredient market revenue, by type of manufacturing, 2015 – 2021 (USD Billion)
56. Latin America active pharmaceutical ingredient market revenue, by Type of API, 2015 – 2021 (USD Billion)
57. Latin America active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
58. Latin America active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion
59. Brazil active pharmaceutical ingredient market revenue, by API synthesis, 2015 – 2021 (USD Billion)
60. Brazil active pharmaceutical ingredient market revenue, by type of manufacturing, 2015 – 2021 (USD Billion)
61. Brazil active pharmaceutical ingredient market revenue, by Type of API, 2015 – 2021 (USD Billion)
62. Brazil active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
63. Brazil active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion
64. Middle East & Africa active pharmaceutical ingredient market revenue, by API synthesis, 2015 – 2021 (USD Billion)
65. Middle East & Africa active pharmaceutical ingredient market revenue, by type of manufacturing, 2015 – 2021 (USD Billion)
66. Middle East & Africa active pharmaceutical ingredient market revenue, by Type of API, 2015 – 2021 (USD Billion)
67. Middle East & Africa active pharmaceutical ingredient market revenue, by drug type, 2015 – 2021 (USD Billion)
68. Middle East & Africa active pharmaceutical ingredient market revenue, by application, 2015 – 2021 (USD Billion)

* Indicates required field.

Your Name*

Your Email*

Telephone Number*

Name of company*

Country Name*

How can we help you?

Prove You are Human*

captcha
Enter Capcha Image Properly



 

Share this Post

Related Posts

Checking...

Ouch! There was a server error.
Retry »

Sending message...

Enquiry Form

Fill in the form below and we will be in touch soon

Create Account



Log In Your Account